InvestorsHub Logo
Followers 253
Posts 17984
Boards Moderated 0
Alias Born 01/19/2006

Re: jessellivermore post# 311111

Saturday, 11/21/2020 3:42:32 PM

Saturday, November 21, 2020 3:42:32 PM

Post# of 426389
JL, Amarin announced (August 7, 2020) that it is supporting a large trial of Vascepa in treating patients afflicted with COVID-19; P-I is Kaiser-Permanente. JT and CG have elaborated on that topic by noting AMRN is supporting 3 randomized, blinded trials of Vascepa in ~ 3500 patients in the United States, Canada and Argentina. See Amarin’s earnings call, 11/05/2020.

Reasons correspond to those you advance.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News